Rapid Dose Therapeutics (RDT) is a Canadian biotech Company that specializes in providing innovative drug delivery technologies to improve patient outcomes. With their proprietary oral delivery platform, utilizing sublingual thin film strip technology, RDT is at the forefront of revolutionizing pharmaceutical administration. RDT's mission is to create enhanced rapid delivery therapeutics that improve healthcare outcomes for patients.

They offer a range of products, including their QuickStrip™ delivery system, which mimics the blood concentrations seen with intravenous injection. This allows for easy absorption of pharmaceuticals, offering comparable uptake speed to intravenous administration. Their product lineup includes over-the-counter options such as Rapid Energy, Vitamins, Vitamin B12, and Melatonin.

RDT also offers dental products, aimed at providing ease of use and convenience. RDT goes beyond offering products; they also provide partnership and collaboration opportunities for companies interested in leveraging their cutting-edge technology. By choosing RDT, partners gain a significant advantage in bringing products to market quickly, thanks to RDT's patented and proven drug delivery systems.

With RDT, patients can expect improved healthcare outcomes, while partners benefit from innovative drug delivery solutions